Consistently, rt-PA administration induces an increase in brain BDNF levels [13] and BDNF can cross the blood brain barrier from the brain to the blood [27] especially since rt-PA has been shown to exacerbate stroke-induced blood brain barrier disruption [7]. The gene discussed is BDNF; the disease is stroke disorder.